Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Daniel Chan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Occupations

Proteomics

Procedures

Anatomy

Prostate

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Chan D W; Liu V W S; To R M Y; Chiu P M; Lee W Y W; Yao K M; Cheung A N Y; Ngan H Y S
Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer.
Song Jin; Shih Ie-ming; Chan Daniel W; Zhang Zhen
Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.
Loeb Stacy; Schaeffer Edward M; Chan Daniel W; Carter H Ballentine; Walsh Patrick C; Sokoll Lori J
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Daniel Chan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Chan D W; Liu V W S; To R M Y; Chiu P M; Lee W Y W; Yao K M; Cheung A N Y; Ngan H Y S
Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer.
British journal of cancer 2009;101(8):1433-43.
2009: Song Jin; Shih Ie-ming; Chan Daniel W; Zhang Zhen
Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.
Neoplasia (New York, N.Y.) 2009;11(6):605-14, 1 p following 614.
2009: Loeb Stacy; Schaeffer Edward M; Chan Daniel W; Carter H Ballentine; Walsh Patrick C; Sokoll Lori J
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
Urology 2009;73(5):947-9.
2009: Rosenzweig C Nicole; Zhang Zhen; Sun Xiaer; Sokoll Lori J; Osborne Katherine; Partin Alan W; Chan Daniel W
Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers.
The Journal of urology 2009;181(3):1407-14.
2009: Meany Danni L; Zhang Zhen; Sokoll Lori J; Zhang Hui; Chan Daniel W
Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.
Journal of proteome research 2009;8(2):613-9.
2009: Tuck Melissa K; Chan Daniel W; Chia David; Godwin Andrew K; Grizzle William E; Krueger Karl E; Rom William; Sanda Martin; Sorbara Lynn; Stass Sanford; Wang Wendy; Brenner Dean E
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.
Journal of proteome research 2009;8(1):113-7.
2008: Sturgeon Catharine M; Duffy Michael J; Stenman Ulf-Håkan; Lilja Hans; Brünner Nils; Chan Daniel W; Babaian Richard; Bast Robert C; Dowell Barry; Esteva Francisco J; Haglund Caj; Harbeck Nadia; Hayes Daniel F; Holten-Andersen Mads; Klee George G; Lamerz Rolf; Looijenga Leendert H; Molina Rafael; Nielsen Hans Jørgen; Rittenhouse Harry; Semjonow Axel; Shih Ie-Ming; Sibley Paul; Sölétormos György; Stephan Carsten; Sokoll Lori; Hoffman Barry R; Diamandis Eleftherios P;
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Clinical chemistry 2008;54(12):e11-79.
2008: Loeb Stacy; Chan Daniel W; Sokoll Lori; Kan Donghui; Maggiore Jack; Mikolajczyk Stephen D; Mondo Dana M; Griffin Chris R; Catalona William J
Prostate specific antigen assay standardization bias could affect clinical decision making.
The Journal of urology 2008;180(5):1959-62; discussion 1962-3.
2008: Sturgeon Catharine M; Hoffman Barry R; Chan Daniel W; Ch'ng Soo-Ling; Hammond Elizabeth; Hayes Daniel F; Liotta Lance A; Petricoin Emmanuel F; Schmitt Manfred; Semmes O John; Söletormos Györg; van der Merwe Elena; Diamandis Eleftherios P;
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
Clinical chemistry 2008;54(8):e1-e10.
2008: Sokoll Lori J; Wang Yinghui; Feng Ziding; Kagan Jacob; Partin Alan W; Sanda Martin G; Thompson Ian M; Chan Daniel W
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study.
The Journal of urology 2008;180(2):539-43; discussion 543.
2008: Chan D W; Yu S Y M; Chiu P M; Yao K M; Liu V W S; Cheung A N Y; Ngan H Y S
Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.
The Journal of pathology 2008;215(3):245-52.
2008: Leman Eddy S; Schoen Robert E; Magheli Ahmed; Sokoll Lori J; Chan Daniel W; Getzenberg Robert H
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1349-54.
2008: McLerran Dale; Grizzle William E; Feng Ziding; Thompson Ian M; Bigbee William L; Cazares Lisa H; Chan Daniel W; Dahlgren Jackie; Diaz Jose; Kagan Jacob; Lin Daniel W; Malik Gunjan; Oelschlager Denise; Partin Alan; Randolph Timothy W; Sokoll Lori; Srivastava Shiv; Srivastava Sudhir; Thornquist Mark; Troyer Dean; Wright George L; Zhang Zhen; Zhu Liu; Semmes O John
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
Clinical chemistry 2008;54(1):53-60.
2008: McLerran Dale; Grizzle William E; Feng Ziding; Bigbee William L; Banez Lionel L; Cazares Lisa H; Chan Daniel W; Diaz Jose; Izbicka Elzbieta; Kagan Jacob; Malehorn David E; Malik Gunjan; Oelschlager Denise; Partin Alan; Randolph Timothy; Rosenzweig Nicole; Srivastava Shiv; Srivastava Sudhir; Thompson Ian M; Thornquist Mark; Troyer Dean; Yasui Yutaka; Zhang Zhen; Zhu Liu; Semmes O John
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
Clinical chemistry 2008;54(1):44-52.
2008: Meany Danni L; Chan Daniel W
Comparability of tumor marker immunoassays: still an important issue for clinical diagnostics?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(5):575-6.
2007: Zhang Zhen; Yu Yinhua; Xu Fengji; Berchuck Andrew; van Haaften-Day Carolien; Havrilesky Laura J; de Bruijn Henk W A; van der Zee Ate G J; Woolas Robert P; Jacobs Ian J; Skates Steven; Chan Daniel W; Bast Robert C
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.
Gynecologic oncology 2007;107(3):526-31.
2007: Song Jin; Shih Ie-ming; Salani Ritu; Chan Daniel W; Zhang Zhen
Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6842-9.
2007: Zhang Hui; Chan Daniel W
Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):1915-7.
2007: Song J; Bai J; Yang W; Gabrielson E W; Chan D W; Zhang Z
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Histopathology 2007;51(1):40-53.
2007: Leman Eddy S; Schoen Robert E; Weissfeld Joel L; Cannon Grant W; Sokoll Lori J; Chan Daniel W; Getzenberg Robert H
Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
Cancer research 2007;67(12):5600-5.
2007: Liang Shu-Ling; Chan Daniel W
Enzymes and related proteins as cancer biomarkers: a proteomic approach.
Clinica chimica acta; international journal of clinical chemistry 2007;381(1):93-7.
2007: Leman Eddy S; Cannon Grant W; Trock Bruce J; Sokoll Lori J; Chan Daniel W; Mangold Leslie; Partin Alan W; Getzenberg Robert H
EPCA-2: a highly specific serum marker for prostate cancer.
Urology 2007;69(4):714-20.
2006: Hortin Glen L; Jortani Saeed A; Ritchie James C; Valdes Roland; Chan Daniel W
Proteomics: a new diagnostic frontier.
Clinical chemistry 2006;52(7):1218-22.
2006: Song Jin; Patel Manisha; Rosenzweig C Nicole; Chan-Li Yee; Sokoll Lori J; Fung Eric T; Choi-Miura Nam-Ho; Goggins Michael; Chan Daniel W; Zhang Zhen
Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
Clinical chemistry 2006;52(6):1045-53.
2006: Koopmann Jens; Rosenzweig C Nicole White; Zhang Zhen; Canto Marcia I; Brown David A; Hunter Mark; Yeo Charles; Chan Daniel W; Breit Samuel N; Goggins Michael
Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):442-6.
2005: Li Jinong; Zhao Jing; Yu Xiaodong; Lange Julie; Kuerer Henry; Krishnamurthy Savitri; Schilling Eric; Khan Seema A; Sukumar Saraswati; Chan Daniel W
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8312-20.
2005: Li Jinong; Orlandi Rosaria; White C Nicole; Rosenzweig Jason; Zhao Jing; Seregni Ettore; Morelli Daniele; Yu Yinhua; Meng Xiao-Ying; Zhang Zhen; Davidson Nancy E; Fung Eric T; Chan Daniel W
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Clinical chemistry 2005;51(12):2229-35.
2005: Zhang Zhen; Chan Daniel W
Cancer proteomics: in pursuit of "true" biomarker discovery.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(10):2283-6.
2005: Martinez Elizabeth A; Nass Caitlin M; Jermyn Roland M; Rosenbaum Stanley H; Akhtar Shamsuddin; Chan Daniel W; Malkus Herbert; Weiss James L; Fleisher Lee A
Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction.
Journal of cardiothoracic and vascular anesthesia 2005;19(5):577-82.
2005: Omenn Gilbert S; States David J; Adamski Marcin; Blackwell Thomas W; Menon Rajasree; Hermjakob Henning; Apweiler Rolf; Haab Brian B; Simpson Richard J; Eddes James S; Kapp Eugene A; Moritz Robert L; Chan Daniel W; Rai Alex J; Admon Arie; Aebersold Ruedi; Eng Jimmy; Hancock William S; Hefta Stanley A; Meyer Helmut; Paik Young-Ki; Yoo Jong-Shin; Ping Peipei; Pounds Joel; Adkins Joshua; Qian Xiaohong; Wang Rong; Wasinger Valerie; Wu Chi Yue; Zhao Xiaohang; Zeng Rong; Archakov Alexander; Tsugita Akira; Beer Ilan; Pandey Akhilesh; Pisano Michael; Andrews Philip; Tammen Harald; Speicher David W; Hanash Samir M
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
Proteomics 2005;5(13):3226-45.
2005: Rai Alex J; Stemmer Paul M; Zhang Zhen; Adam Bao-Ling; Morgan William T; Caffrey Rebecca E; Podust Vladimir N; Patel Manisha; Lim Lih-Yin; Shipulina Natalia V; Chan Daniel W; Semmes O John; Leung Hon-Chiu Eastwood
Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
Proteomics 2005;5(13):3467-74.
2005: Rai Alex J; Gelfand Craig A; Haywood Bruce C; Warunek David J; Yi Jizu; Schuchard Mark D; Mehigh Richard J; Cockrill Steven L; Scott Graham B I; Tammen Harald; Schulz-Knappe Peter; Speicher David W; Vitzthum Frank; Haab Brian B; Siest Gerard; Chan Daniel W
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Proteomics 2005;5(13):3262-77.
2005: Colantonio David A; Chan Daniel W
The clinical application of proteomics.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):151-8.
2005: Fung Eric T; Yip Tai-Tung; Lomas Lee; Wang Zheng; Yip Christine; Meng Xiao-Ying; Lin Shanhua; Zhang Fujun; Zhang Zhen; Chan Daniel W; Weinberger Scot R
Classification of cancer types by measuring variants of host response proteins using SELDI serum assays.
International journal of cancer. Journal international du cancer 2005;115(5):783-9.
2005: Haese Alexander; Vaisanen Ville; Lilja Hans; Kattan Michael W; Rittenhouse Harry G; Pettersson Kim; Chan Daniel W; Huland Hartwig; Sokoll Lori J; Partin Alan W
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
The Journal of urology 2005;173(3):752-6.
2005: Semmes O John; Feng Ziding; Adam Bao-Ling; Banez Lionel L; Bigbee William L; Campos David; Cazares Lisa H; Chan Daniel W; Grizzle William E; Izbicka Elzbieta; Kagan Jacob; Malik Gunjan; McLerran Dale; Moul Judd W; Partin Alan; Prasanna Premkala; Rosenzweig Jason; Sokoll Lori J; Srivastava Shiv; Srivastava Sudhir; Thompson Ian; Welsh Manda J; White Nicole; Winget Marcy; Yasui Yutaka; Zhang Zhen; Zhu Liu
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
Clinical chemistry 2005;51(1):102-12.
2005: Horowitz Gary L; Zaman Zahur; Blanckaert Norbert J C; Chan Daniel W; Dubois Jeffrey A; Golaz Olivier; Mensi Noury; Keller Franz; Stolz Herbert; Klingler Karl; Marocchi Alessandro; Prencipe Lorenzo; McLawhon Ronald W; Nilsen Olaug L; Oellerich Michael; Luthe Hilmar; Orsonneau Jean-Luc; Richeux Gérard; Recio Fernando; Roldan Esther; Rymo Lars; Wicktorsson Anne-Charlotte; Welch Shirley L; Wieland Heinrich; Grawitz Andrea Busse; Mitsumaki Hiroshi; McGovern Margaret; Ng Katherine; Stockmann Wolfgang
MODULAR ANALYTICS: A New Approach to Automation in the Clinical Laboratory.
Journal of automated methods & management in chemistry 2005;2005():8-25.
2005: Clarke William; Chan Daniel W
ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(12):1279-80.
2005: White C Nicole; Zhang Zhen; Chan Daniel W
Quality control for SELDI analysis.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(2):125-6.
2004: Khan Masood A; Sokoll Lori J; Chan Daniel W; Mangold Leslie A; Mohr Phaedre; Mikolajczyk Stephen D; Linton Harry J; Evans Cindy L; Rittenhouse Harry G; Partin Alan W
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.
Urology 2004;64(6):1160-4.
2004: Gretzer M B; Chan D W; van Rootselaar C L; Rosenzweig J M; Dalrymple S; Mangold L A; Partin A W; Veltri R W
Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
The Prostate 2004;60(4):325-31.
2004: Zhang Zhen; Bast Robert C; Yu Yinhua; Li Jinong; Sokoll Lori J; Rai Alex J; Rosenzweig Jason M; Cameron Bonnie; Wang Young Y; Meng Xiao-Ying; Berchuck Andrew; Van Haaften-Day Carolien; Hacker Neville F; de Bruijn Henk W A; van der Zee Ate G J; Jacobs Ian J; Fung Eric T; Chan Daniel W
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.
Cancer research 2004;64(16):5882-90.
2004: Wang Young Y; Kuhajda Francis P; Li Jinong; Finch Teia T; Cheng Paul; Koh Clare; Li Tianwei; Sokoll Lori J; Chan Daniel W
Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer.
Journal of experimental therapeutics & oncology 2004;4(2):101-10.
2004: White C Nicole; Chan Daniel W; Zhang Zhen
Bioinformatics strategies for proteomic profiling.
Clinical biochemistry 2004;37(7):636-41.
2004: Rai Alex J; Chan Daniel W
Cancer proteomics: Serum diagnostics for tumor marker discovery.
Annals of the New York Academy of Sciences 2004;1022():286-94.
2004: Li Jinong; White Nicole; Zhang Zhen; Rosenzweig Jason; Mangold Leslie A; Partin Alan W; Chan Daniel W
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population.
The Journal of urology 2004;171(5):1782-7.
2004: Koopmann Jens; Buckhaults Phillip; Brown David A; Zahurak Marianna L; Sato Norihiro; Fukushima Noriyoshi; Sokoll Lori J; Chan Daniel W; Yeo Charles J; Hruban Ralph H; Breit Samuel N; Kinzler Kenneth W; Vogelstein Bert; Goggins Michael
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2386-92.
2004: Koopmann Jens; Zhang Zhen; White Nicole; Rosenzweig Jason; Fedarko Neal; Jagannath Sanjay; Canto Marcia I; Yeo Charles J; Chan Daniel W; Goggins Michael
Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):860-8.
2004: Bieglmayer Christian; Chan Daniel W; Sokoll Lori; Imdahl Roland; Kobayashi Masaji; Yamada Erike; Lilje Diana J; Luthe Hilmar; Meissner Jochen; Messeri Gianni; Celli Alessandra; Tozzi Paola; Roth Heinz-Jürgen; Schmidt Frank-Peter; Mächler Marie-Luise; Schuff-Werner Peter; Zingler Christiana; Smitz Johan; Schiettecatte Johan; Vonderschmitt Dieter J; Pei Patrick; Ng Katherine; Ebert Christoph; Kirch Peter; Wanger Michael; McGovern Margaret; Stockmann Wolfgang; Kuns Albert
Multicentre performance evaluation of the E170 module for modular analytics.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(10):1186-202.
2004: Kunz George M; Chan Daniel W
The use of laser capture microscopy in proteomics research--a review.
Disease markers 2004;20(3):155-60.
2003: Park Jae; Sokoll Lori J; Bruzek Debra J; Mangold Leslie; Gurganus Robin; Khan Masood A; Partin Alan W; Chan Daniel W; Veltri Robert W
Comparison of total prostate-specific antigen and derivative levels in a screening population of black, white, and Korean-American men.
Clinical prostate cancer 2003;2(3):173-6.
2003: Clarke William; Zhang Zhen; Chan Daniel W
The application of clinical proteomics to cancer and other diseases.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(12):1562-70.
2003: Naya Yoshio; Fritsche Herbert A; Cheli Carol D; Stamey Thomas A; Bartsch Georg; Brawer Michael K; Childs Stacy; Taneja Samir S; Lepor Herbert; Partin Alan W; Sokoll Lori J; Chan Daniel W; Babaian Richard J
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
Urology 2003;62(6):1058-62.
2003: Partin Alan W; Brawer Michael K; Bartsch Georg; Horninger Wolfgang; Taneja Samir S; Lepor Herbert; Babaian Richard; Childs Stacy J; Stamey Thomas; Fritsche Herbert A; Sokoll Lori; Chan Daniel W; Thiel Robert P; Cheli Carol D
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
The Journal of urology 2003;170(5):1787-91.
2003: Singer Gad; Rebmann Vera; Chen Yu-Chi; Liu Hsu-Tai; Ali Syed Z; Reinsberg Jochen; McMaster Michael T; Pfeiffer Kerstin; Chan Daniel W; Wardelmann Eva; Grosse-Wilde Hans; Cheng Chih-Chien; Kurman Robert J; Shih Ie-Ming
HLA-G is a potential tumor marker in malignant ascites.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4460-4.
2003: Khan Masood A; Partin Alan W; Rittenhouse Harry G; Mikolajczyk Stephen D; Sokoll Lori J; Chan Daniel W; Veltri Robert W
Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.
The Journal of urology 2003;170(3):723-6.
2003: Wang Brant G; Huang Han-Yao; Chen Yu-Chi; Bristow Robert E; Kassauei Keyanunoosh; Cheng Chih-Chien; Roden Richard; Sokoll Lori J; Chan Daniel W; Shih Ie-Ming
Increased plasma DNA integrity in cancer patients.
Cancer research 2003;63(14):3966-8.
2003: Clarke William; Silverman Benjamin C; Zhang Zhen; Chan Daniel W; Klein Andrew S; Molmenti Ernesto P
Characterization of renal allograft rejection by urinary proteomic analysis.
Annals of surgery 2003;237(5):660-4; discussion 664-5.
2003: Haese Alexander; Vaisanen Ville; Finlay Judith A; Pettersson Kim; Rittenhouse Harry G; Partin Alan W; Bruzek Debra J; Sokoll Lori J; Lilja Hans; Chan Daniel W
Standardization of two immunoassays for human glandular kallikrein 2.
Clinical chemistry 2003;49(4):601-10.
2003: Wang Young Y; Cheng Paul; Chan Daniel W
A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis.
Proteomics 2003;3(3):243-8.
2003: Sokoll Lori J; Chan Daniel W; Mikolajczyk Stephen D; Rittenhouse Harry G; Evans Cindy L; Linton Harry J; Mangold Leslie A; Mohr Phaedre; Bartsch Georg; Klocker Helmut; Horninger Wolfgang; Partin Alan W
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis.
Urology 2003;61(2):274-6.
2003: Gretzer Matthew B; Partin Alan W; Chan Daniel W; Veltri Robert W
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI).
Reviews in urology 2003;5(2):81-9.
2003: Stieber Petra; Molina Rafael; Chan Daniel W; Fritsche Herbert A; Beyrau Ralf; Bonfrer Jean M G; Filella Xavier; Gornet Terrie G; Hoff Torsten; Jäger Wolfram; van Kamp Gerard J; Nagel Dorothea; Peisker Klaus; Sokoll Lori J; Troalen Frédéric; Untch Michael; Domke Ingrid
Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients.
Clinical laboratory 2003;49(1-2):15-24.
2002: Rai Alex J; Zhang Zhen; Rosenzweig Jason; Shih Ie-Ming; Pham Thang; Fung Eric T; Sokoll Lori J; Chan Daniel W
Proteomic approaches to tumor marker discovery.
Archives of pathology & laboratory medicine 2002;126(12):1518-26.
2002: Wians Frank H; Cheli Carol D; Balko Jody A; Bruzek Debra J; Chan Daniel W; Sokoll Lori J
Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancer.
Clinica chimica acta; international journal of clinical chemistry 2002;326(1-2):81-95.
2002: Chang Hsueh-Wei; Lee Shing M; Goodman Steven N; Singer Gad; Cho Sarah K R; Sokoll Lori J; Montz Fredrick J; Roden Richard; Zhang Zhen; Chan Daniel W; Kurman Robert J; Shih Ie-Ming
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
Journal of the National Cancer Institute 2002;94(22):1697-703.
2002: Kim Lauren J; Martinez Elizabeth A; Faraday Nauder; Dorman Todd; Fleisher Lee A; Perler Bruce A; Williams G Melville; Chan Daniel; Pronovost Peter J
Cardiac troponin I predicts short-term mortality in vascular surgery patients.
Circulation 2002;106(18):2366-71.
2002: Naya Yoshio; Stamey Thomas A; Cheli Carol D; Partin Alan W; Sokoll Lori J; Chan Daniel W; Brawer Michael K; Taneja Samir S; Lepor Herbert; Bartsch Georg; Childs Stacy; Fritsche Herbert A; Babaian Richard J
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Urology 2002;60(4 Suppl 1):36-41.
2002: Horninger Wolfgang; Cheli Carol D; Babaian Richard J; Fritsche Herbert A; Lepor Herbert; Taneja Samir S; Childs Stacy; Stamey Thomas A; Sokoll Lori J; Chan Daniel W; Brawer Michael K; Partin Alan W; Bartsch Georg
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
Urology 2002;60(4 Suppl 1):31-5.
2002: Sokoll Lori J; Bruzek Debra J; Dua Renu; Dunn Willard; Mohr Phaedre; Wallerson Gail; Eisenberger Mario; Partin Alan W; Chan Daniel W
Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen.
Urology 2002;60(4 Suppl 1):24-30.
2002: Sokoll Lori J; Mangold Leslie A; Partin Alan W; Epstein Jonathan I; Bruzek Debra J; Dunn Willard; Mohr Phaedre; Wallerson Gail; Chan Daniel W
Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men.
Urology 2002;60(4 Suppl 1):18-23.
2002: Taneja Samir S; Hsu Elias I; Cheli Carol D; Walden Paul; Bartsch Georg; Horninger Wolfgang; Babaian Richard J; Fritsche Herbert A; Childs Stacy; Stamey Thomas A; Sokoll Lori J; Chan Daniel W; Brawer Michael K; Partin Alan W; Lepor Herbert
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
Urology 2002;60(4 Suppl 1):10-7.
2002: Li Jinong; Zhang Zhen; Rosenzweig Jason; Wang Young Y; Chan Daniel W
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Clinical chemistry 2002;48(8):1296-304.
2002: Haese Alexander; Dworschack Robert T; Piccoli Steven P; Sokoll Lori J; Partin Alan W; Chan Daniel W
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systems.
Clinical chemistry 2002;48(6 Pt 1):944-7.
2002: Wright E James; Fang Junyong; Metter E Jeffrey; Partin Alan W; Landis Patricia; Chan Daniel W; Carter H Ballentine
Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging.
The Journal of urology 2002;167(6):2484-7; discussion 2487-8.
2002: Okihara Koji; Cheli Carol D; Partin Alan W; Fritche Herbert A; Chan Daniel W; Sokoll Lori J; Brawer Michael K; Schwartz Morton K; Vessella Robert L; Loughlin Kevin R; Johnston Dennis A; Babaian R Joseph
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.
The Journal of urology 2002;167(5):2017-23; discussion 2023-4.
2002: Rosty Christophe; Christa Laurence; Kuzdzal Scott; Baldwin William M; Zahurak Marianna L; Carnot Françoise; Chan Daniel W; Canto Marcia; Lillemoe Keith D; Cameron John L; Yeo Charles J; Hruban Ralph H; Goggins Michael
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
Cancer research 2002;62(6):1868-75.
2002: Wang Young Y; Kuhajda Francis P; Cheng Paul; Chee Wey Yeeng; Li Tianwei; Helzlsouer Kathy J; Sokoll Lori J; Chan Daniel W
A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthase.
Journal of immunoassay & immunochemistry 2002;23(3):279-92.
2001: Stieber P; Molina R; Chan D W; Fritsche H A; Beyrau R; Bonfrer J M; Filella X; Gornet T G; Hoff T; Jäger W; van Kamp G J; Nagel D; Peisker K; Sokoll L J; Troalen F; Untch M; Domke I
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay.
Clinical chemistry 2001;47(12):2162-4.
2001: Luppa P B; Sokoll L J; Chan D W
Immunosensors--principles and applications to clinical chemistry.
Clinica chimica acta; international journal of clinical chemistry 2001;314(1-2):1-26.
2001: Brooks J D; Metter E J; Chan D W; Sokoll L J; Landis P; Nelson W G; Muller D; Andres R; Carter H B
Plasma selenium level before diagnosis and the risk of prostate cancer development.
The Journal of urology 2001;166(6):2034-8.
2001: Chance J J; Segal J B; Wallerson G; Kasper E; Hruban R H; Kickler T S; Chan D W
Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection.
Clinica chimica acta; international journal of clinical chemistry 2001;312(1-2):31-9.
2001: Fang J; Metter E J; Landis P; Chan D W; Morrell C H; Carter H B
Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging.
Urology 2001;58(3):411-6.
2001: Denmeade S R; Sokoll L J; Chan D W; Khan S R; Isaacs J T
Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.
The Prostate 2001;48(1):1-6.
2001: Wang Y; Kuhajda F P; Li J N; Pizer E S; Han W F; Sokoll L J; Chan D W
Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients.
Cancer letters 2001;167(1):99-104.
2001: Han M; Piantadosi S; Zahurak M L; Sokoll L J; Chan D W; Epstein J I; Walsh P C; Partin A W
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Urology 2001;57(4):707-11.
2001: Cook G B; Neaman I E; Goldblatt J L; Cambetas D R; Hussain M; Lüftner D; Yeung K K; Chan D W; Schwartz M K; Allard W J
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer.
Anticancer research 2001;21(2B):1465-70.
2001: Wang Y; Kuhajda F P; Sokoll L J; Chan D W
Two-site ELISA for the quantitative determination of fatty acid synthase.
Clinica chimica acta; international journal of clinical chemistry 2001;304(1-2):107-15.
2001: Laffin R J; Chan D W; Tanasijevic M J; Fischer G A; Markus W; Miller J; Matarrese P; Sokoll L J; Bruzek D J; Eneman J; Nelson J; Bray K R; Huang J; Loveland K G
Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system: a multicenter evaluation of analytical performance.
Clinical chemistry 2001;47(1):129-32.
2000: Sokoll L J; Witte D L; Klee G G; Chan D W
Redesigned proficiency testing materials improve survey outcomes for prostate-specific antigen. A College of American Pathologists Ligand Assay Survey tool.
Archives of pathology & laboratory medicine 2000;124(11):1608-13.
2000: Green G B; Dehlinger E; McGrievey T S; Li D J; Jones K A; Kelen G D; Chan D W
CK-MB isoforms for early risk stratification of emergency department patients.
Clinica chimica acta; international journal of clinical chemistry 2000;300(1-2):57-73.
2000: Chan D W; Sokoll L J
WHO first international standards for prostate-specific antigen: the beginning of the end for assay discrepancies?
Clinical chemistry 2000;46(9):1291-2.
2000: Green G B; Skarbek-Borowski G W; Chan D W; Kelen G D
Myoglobin for early risk stratification of emergency department patients with possible myocardial ischemia.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2000;7(6):625-36.
2000: Vessella R L; Lange P H; Partin A W; Chan D W; Sokoll L J; Sasse E A; Crawford E D
Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays.
Urology 2000;55(6):909-14.
2000: Shih I M; Torrance C; Sokoll L J; Chan D W; Kinzler K W; Vogelstein B
Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin.
Nature medicine 2000;6(6):711-4.
2000: Udelsman R; Osterman F; Sokoll L J; Drew H; Levine M A; Chan D W
Rapid parathyroid hormone measurement during venous localization.
Clinica chimica acta; international journal of clinical chemistry 2000;295(1-2):193-8.
2000: Brawer M K; Cheli C D; Neaman I E; Goldblatt J; Smith C; Schwartz M K; Bruzek D J; Morris D L; Sokoll L J; Chan D W; Yeung K K; Partin A W; Allard W J
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
The Journal of urology 2000;163(5):1476-80.
1999: Wang T J; Linton H J; Payne J; Rittenhouse H G; Chan D W; Partin A W; Wolfert R L; Kuus-Reichel K
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Hybridoma 1999;18(6):535-41.
1999: Partin A W; Catalona W J; Finlay J A; Darte C; Tindall D J; Young C Y; Klee G G; Chan D W; Rittenhouse H G; Wolfert R L; Woodrum D L
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.
Urology 1999;54(5):839-45.
1999: Chan D W; Kelley C A; Ratliff T L; D'Agostino D; Ritchey J; Lamb D J; Beck J; Lott N; Wener M H; Daum P; Henkin R E; Kaske D N; Golightly D W; McBride J; Layco G; Ota M K; Tanasijevic M J; Grudzien C; Woodrum D L; Bray K R; Southwick P C; Gasior G H; Loveland K G
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen.
Clinical chemistry 1999;45(10):1863-5.
1999: Catalona W J; Partin A W; Finlay J A; Chan D W; Rittenhouse H G; Wolfert R L; Woodrum D L
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.
Urology 1999;54(2):220-4.
1999: Hubl W; Chan D W; Van Ingen H E; Miyachi H; Molina R; Filella X; Pitzel L; Ruibal A; Rymer J C; Bagnard G; Domke I
Multicenter evaluation of the Elecsys CA 125 II assay.
Anticancer research 1999;19(4A):2727-33.
1999: Rittenhouse H G; Chan D W
Can complexed PSA be used as a single test for detecting prostate cancer?
Urology 1999;54(1):4-5.
1999: Sokoll L J; Chan D W
Clinical analyzers. Immunoassays.
Analytical chemistry 1999;71(12):356R-362R.
1999: Chan D W; Sokoll L J
Prostate-specific antigen: advances and challenges.
Clinical chemistry 1999;45(6 Pt 1):755-6.
1999: Pound C R; Partin A W; Eisenberger M A; Chan D W; Pearson J D; Walsh P C
Natural history of progression after PSA elevation following radical prostatectomy.
JAMA : the journal of the American Medical Association 1999;281(17):1591-7.
1999: Allard W J; Cheli C D; Morris D L; Goldblatt J; Pierre Y; Kish L; Chen Y; Dai J; Vessella R L; Chan D W; Schwartz M K; Zhou Z; Yeung K K
Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1 complexed PSA assay.
The International journal of biological markers 1999;14(2):73-83.
1999: Magriples U; Chan D W; Bruzek D; Copel J A; Hsu C D
Thrombomodulin: a new marker for placental abruption.
Thrombosis and haemostasis 1999;81(1):32-4.
1999: Sokoll L J; Partin A W; Nelson J B; Chan D W
Critical analysis of false elevations in PSA results reported with the Abbott AxSYM assay.
The Prostate 1999;38(1):79-80.
1998: Cina S J; Li D J; Chan D W; Boitnott J K; Hruban R H; Smialek J E
Serum concentrations of cardiac troponin I in sudden death: a pilot study.
The American journal of forensic medicine and pathology : official publication of the National Association of Medical Examiners 1998;19(4):324-8.
1998: van Ingen H E; Chan D W; Hubl W; Miyachi H; Molina R; Pitzel L; Ruibal A; Rymer J C; Domke I
Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125.
Clinical chemistry 1998;44(12):2530-6.
1998: Epstein J I; Chan D W; Sokoll L J; Walsh P C; Cox J L; Rittenhouse H; Wolfert R; Carter H B
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.
The Journal of urology 1998;160(6 Pt 2):2407-11.
1998: Green G B; Li D J; Bessman E S; Cox J L; Kelen G D; Chan D W
The prognostic significance of troponin I and troponin T.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 1998;5(8):758-67.
1998: Miller L R; Partin A W; Chan D W; Bruzek D J; Dobs A S; Epstein J I; Walsh P C
Influence of radical prostatectomy on serum hormone levels.
The Journal of urology 1998;160(2):449-53.
1998: Cheli C D; Morris D L; Kish L; Goldblatt J; Neaman I; Allard W J; Yeung K K; Wu A H; Moore R; Chan D W; Fritsche H A; Schwartz M K; Very D L
Multicenter evaluation of the Bayer Immuno I CA 15-3 assay.
Clinical chemistry 1998;44(4):765-72.
1998: Pannek J; Rittenhouse H G; Chan D W; Epstein J I; Walsh P C; Partin A W
The use of percent free prostate specific antigen for staging clinically localized prostate cancer.
The Journal of urology 1998;159(4):1238-42.
1998: Pannek J; Marks L S; Pearson J D; Rittenhouse H G; Chan D W; Shery E D; Gormley G J; Subong E N; Kelley C A; Stoner E; Partin A W
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia.
The Journal of urology 1998;159(2):449-53.
1998: Zhou W; Sokoll L J; Bruzek D J; Zhang L; Velculescu V E; Goldin S B; Hruban R H; Kern S E; Hamilton S R; Chan D W; Vogelstein B; Kinzler K W
Identifying markers for pancreatic cancer by gene expression analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(2):109-12.
1998: Green G B; Beaudreau R W; Chan D W; DeLong D; Kelley C A; Kelen G D
Use of troponin T and creatine kinase-MB subunit levels for risk stratification of emergency department patients with possible myocardial ischemia.
Annals of emergency medicine 1998;31(1):19-29.
1998: Lynch D M; Rogers P E; Love J C; Salkas M J; Skarphol K A; Gross M E; Lu M G; Petrides V H; Bruzek D J; Cox J L; Jones K A; Kelley C A; Chan D W
Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(6):421-38.
1998: Uhl W; Chan D W; Jones K; Kelley C; Assmann G; von Eckardstein A; Sägers A; Yvert J P; Schneider A M; Torralba A; Fuentes-Arderiu X; Gonzalez de la Presa B; Vives M; Greiling H; Eberle A; Niederau C M; Cremer P; Reiter W; Vogeser M; Neumeier D; Luppa P; Huber U
Elecsys CEA, PSA and AFP. Clinical results of a multicentre evaluation.
Wiener klinische Wochenschrift 1998;110 Suppl 3():51-61.
1998: Morris D L; Dillon P W; Very D L; Ng P; Kish L; Goldblatt J L; Bruzek D J; Chan D W; Ahmed M S; Witek D; Fritsche H A; Smith C; Schwartz D; Schwartz M K; Noteboom J L; Vessella R L; Yeung K K; Allard W J
Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serum.
Journal of clinical laboratory analysis 1998;12(1):65-74.
1997: Sokoll L J; Kroll M H; Levine M A; Poordad F F; Chan D W
Bone to total alkaline phosphatase ratios improve sensitivity and specificity of bone alkaline phosphatase immunoassays.
Clinical biochemistry 1997;30(8):625-9.
1997: Steele B W; Witte D L; Whitley R J; Klee G G; Chan D W
The effects of modifying proficiency testing materials on thyroid function test results. A College of American Pathologists Ligand Assay Survey Study.
Archives of pathology & laboratory medicine 1997;121(12):1241-6.
1997: Magriples U; Hsu C D; Chan D W; Nickless N; Copel J A
Circulating thrombomodulin levels and clinical correlates in pregnant diabetics.
American journal of perinatology 1997;14(10):605-8.
1997: Pannek J; Rittenhouse H G; Evans C L; Finlay J A; Bruzek D J; Cox J L; Chan D W; Subong E N; Partin A W
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
Urology 1997;50(5):715-21.
1997: Chan D W; Sokoll L J
Prostate-specific antigen: update 1997.
Journal of the International Federation of Clinical Chemistry / IFCC 1997;9(3):120-5.
1997: Chan D W; Beveridge R A; Muss H; Fritsche H A; Hortobagyi G; Theriault R; Kiang D; Kennedy B J; Evelegh M
Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2322-8.
1997: Anderson D J; Guo B; Xu Y; Ng L M; Kricka L J; Skogerboe K J; Hage D S; Schoeff L; Wang J; Sokoll L J; Chan D W; Ward K M; Davis K A
Clinical chemistry.
Analytical chemistry 1997;69(12):165R-229R.
1997: Hsu C D; Copel J A; Chan D W
Antepartum and postpartum thrombomodulin levels in preeclamptic and normotensive pregnancies.
Journal of the Society for Gynecologic Investigation 1997;4(3):135-7.
1997: Carter H B; Epstein J I; Chan D W; Fozard J L; Pearson J D
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
JAMA : the journal of the American Medical Association 1997;277(18):1456-60.
1997: Sokoll L J; Chan D W
Prostate-specific antigen. Its discovery and biochemical characteristics.
The Urologic clinics of North America 1997;24(2):253-9.
1997: Carter H B; Partin A W; Luderer A A; Metter E J; Landis P; Chan D W; Fozard J L; Pearson J D
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis.
Urology 1997;49(3):379-84.
1997: Silver R I; Partin A W; Epstein J I; Chan D W; Carter H B; Jeffs R D; Gearhart J P
Prostate-specific antigen in men born with bladder exstrophy.
Urology 1997;49(2):253-6.
1997: Pound C R; Walsh P C; Epstein J I; Chan D W; Partin A W
Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer.
World journal of urology 1997;15(6):373-7.
1996: Partin A W; Catalona W J; Southwick P C; Subong E N; Gasior G H; Chan D W
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age.
Urology 1996;48(6A Suppl):55-61.
1996: Pannek J; Subong E N; Jones K A; Marschke P L; Epstein J I; Chan D W; Carter H B; Luderer A A; Partin A W
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer.
Urology 1996;48(6A Suppl):51-4.
1996: Thiel R P; Oesterling J E; Wojno K J; Partin A W; Chan D W; Carter H B; Stamey T A; Prestigiacomo A R; Brawer M K; Petteway J C; Carlson G; Luderer A A
Multicenter comparison of the diagnostic performance of free prostate-specific antigen.
Urology 1996;48(6A Suppl):45-50.
1996: Pearson J D; Luderer A A; Metter E J; Partin A W; Chan D W; Fozard J L; Carter H B
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer.
Urology 1996;48(6A Suppl):4-9.
1996: Partin A W; Piantadosi S; Subong E N; Kelly C A; Hortopan S; Chan D W; Wolfert R L; Rittenhouse H G; Carter H B
Clearance rate of serum-free and total PSA following radical retropubic prostatectomy.
The Prostate. Supplement 1996;7():35-9.
1995: Hsu C D; Copel J A; Hong S F; Chan D W
Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension.
Obstetrics and gynecology 1995;86(6):897-9.
1995: Carter H B; Pearson J D; Metter E J; Chan D W; Andres R; Fozard J L; Rosner W; Walsh P C
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
The Prostate 1995;27(1):25-31.
1995: Chan D W
Clinical instrumentation (immunoassay analyzers).
Analytical chemistry 1995;67(12):519R-524R.
1995: Hsu C D; Smith K; Hong S F; Johnson T R; Gollin Y; Chan D W
Does preeclamptic pregnancy increase fetal-maternal hemorrhage?
American journal of perinatology 1995;12(3):205-7.
1995: Carter H B; Pearson J D; Waclawiw Z; Metter E J; Chan D W; Guess H A; Walsh P C
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.
Urology 1995;45(4):591-6.
1995: Nichols J H; Howard C; Loman K; Miller C; Nyberg D; Chan D W
Laboratory and bedside evaluation of portable glucose meters.
American journal of clinical pathology 1995;103(2):244-51.
1995: Hsu C D; Chan D W; Iriye B; Johnson T R; Hong S F; Petri M
Plasma thrombomodulin levels in women with systemic lupus erythematosus.
American journal of perinatology 1995;12(1):27-9.
1994: Hsu C D; Lucas R B; Johnson T R; Hong S F; Chan D W
Elevated urine thrombomodulin/creatinine ratio in severely preeclamptic pregnancies.
American journal of obstetrics and gynecology 1994;171(3):854-6.
1994: Hsu C D; Chan D W; Iriye B; Johnson T R; Hong S F; Repke J T
Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia.
American journal of obstetrics and gynecology 1994;170(4):1135-8.
1994: Chan D W; Beveridge R A; Bhargava A; Wilcox P M; Kennedy M J; Schwartz M K
Breast cancer marker Ca549. A multicenter study.
American journal of clinical pathology 1994;101(4):465-70.
1993: Chan D W
Automation of thyroid function testing.
Clinics in laboratory medicine 1993;13(3):631-44.
1993: Hsu C D; Iriye B; Johnson T R; Witter F R; Hong S F; Chan D W
Elevated circulating thrombomodulin in severe preeclampsia.
American journal of obstetrics and gynecology 1993;169(1):148-9.
1993: Chan D W
The Chinese General Health Questionnaire in a psychiatric setting: the development of the Chinese scaled version.
Social psychiatry and psychiatric epidemiology 1993;28(3):124-9.
1993: Partin A W; Yoo J; Carter H B; Pearson J D; Chan D W; Epstein J I; Walsh P C
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
The Journal of urology 1993;150(1):110-4.
1993: Moses B L; Chan D W; Hruban R H; Forastiere A; Richtsmeier W J
Comparison of intra-arterial and intravenous infusion of cisplatin for head and neck squamous cell carcinoma in a modified rat model.
Archives of otolaryngology--head & neck surgery 1993;119(6):612-7.
1992: Burnett A L; Chan D W; Brendler C B; Walsh P C
The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
The Journal of urology 1992;148(6):1832-4.
1992: Carter H B; Morrell C H; Pearson J D; Brant L J; Plato C C; Metter E J; Chan D W; Fozard J L; Walsh P C
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
Cancer research 1992;52(12):3323-8.
1992: Kelen G D; Green G B; Purcell R H; Chan D W; Qaqish B F; Sivertson K T; Quinn T C
Hepatitis B and hepatitis C in emergency department patients.
The New England journal of medicine 1992;326(21):1399-404.
1992: Carter H B; Pearson J D; Metter E J; Brant L J; Chan D W; Andres R; Fozard J L; Walsh P C
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.
JAMA : the journal of the American Medical Association 1992;267(16):2215-20.
1991: Green G B; Hansen K N; Chan D W; Guerci A D; Fleetwood D H; Sivertson K T; Kelen G D
The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarction.
Annals of emergency medicine 1991;20(9):954-60.
1991: Chan D W; Gao Y M
Variants of prostate-specific antigen separated by concanavalin A.
Clinical chemistry 1991;37(6):1133-4.
1991: Fisher R S; Chan D W; Bare M; Lesser R P
Capillary prolactin measurement for diagnosis of seizures.
Annals of neurology 1991;29(2):187-90.
1990: Carter H B; Partin A W; Epstein J I; Chan D W; Walsh P C
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
The Journal of urology 1990;144(5):1167-70; discussion 1170-1.
1990: Partin A W; Carter H B; Chan D W; Epstein J I; Oesterling J E; Rock R C; Weber J P; Walsh P C
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
The Journal of urology 1990;143(4):747-52.
1989: Shurbaji M S; Beveridge R A; Chan D W; Rock R C; Kuhajda F P
CA-549: immunohistochemistry and serum levels in breast carcinoma and other neoplasms.
Annals of clinical and laboratory science 1989;19(6):408-14.
1989: Weber J P; Oesterling J E; Peters C A; Partin A W; Chan D W; Walsh P C
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.
The Journal of urology 1989;141(4):987-92.
1989: Walsh P C; Oesterling J E; Epstein J I; Bruzek D J; Rock R C; Chan D W
The value of prostate-specific antigen in the management of localized prostatic cancer.
Progress in clinical and biological research 1989;303():27-33.
1988: Beveridge R A; Chan D W; Bruzek D; Damron D; Bray K R; Gaur P K; Ettinger D S; Rock R C; Shurbaji M S; Kuhajda F P
A new biomarker in monitoring breast cancer: CA 549.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1815-21.
1988: Chan D W; Beveridge R A; Bruzek D J; Damron D J; Bray K R; Gaur P K; Ettinger D S; Rock R C
Monitoring breast cancer with CA 549.
Clinical chemistry 1988;34(10):2000-4.
1988: Oesterling J E; Chan D W; Epstein J I; Kimball A W; Bruzek D J; Rock R C; Brendler C B; Walsh P C
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
The Journal of urology 1988;139(4):766-72.
1988: Kelsten M L; Chan D W; Bruzek D J; Rock R C
Monitoring hepatocellular carcinoma by using a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Clinical chemistry 1988;34(1):76-81.
1987: Rock R C; Chan D W; Bruzek D; Waldron C; Oesterling J; Walsh P
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
Clinical chemistry 1987;33(12):2257-61.
1987: Chan D W; Bruzek D J; Oesterling J E; Rock R C; Walsh P C
Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.
Clinical chemistry 1987;33(10):1916-20.
1987: Wu A H; Wong S S; Waldron C; Chan D W
Automated quantification of choriogonadotropin: analytical correlation between serum and urine with creatinine correction.
Clinical chemistry 1987;33(8):1424-6.
1986: Chan D W; Miao Y C
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Clinical chemistry 1986;32(12):2143-6.
1986: Chan D W; Kelsten M; Rock R; Bruzek D
Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Clinical chemistry 1986;32(7):1318-22.
1985: Chan D W; Taylor E; Frye R; Blitzer R L
Immunoenzymetric assay for creatine kinase MB with subunit-specific monoclonal antibodies compared with an immunochemical method and electrophoresis.
Clinical chemistry 1985;31(3):465-9.
1983: Chan D W; Waud J M; Taylor E; Stem J; Drew H; Oropeza M; Sucupira M S
Meaning of serum free-thyroxin values in nonthyroidal illnesses: seven methods compared.
Clinical chemistry 1983;29(12):2091-3.
1983: Waud J M; Chan D W; Drew H M; Oropeza M J; Sucupira M S; Scheinin B; Garrison G M; Mayo M; Taylor E; Stem J
Clinical evaluation of two direct procedures for free thyroxin, and of free thyroxin index determined nonisotopically and by measuring thyroxin-binding globulin.
Clinical chemistry 1983;29(11):1908-11.
1983: Chan D W; Waud J M; Hsu T H
Clinical assessment of a radioimmunoassay for free thyroxine using a modified tracer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1983;24(6):498-504.
1981: Chan D W; Bill M J; Rosenshein N
Specific binding proteins for human chorionic gonadotrophin in a patient with trophoblastic disease.
American journal of clinical pathology 1981;76(2):214-6.
1981: Rock R C; Chan D W; Perlstein M T
Endocrine assays in the monitoring of pregnancy.
Clinics in laboratory medicine 1981;1(2):157-79.
1980: Chan D W; Derkac M
An assessment of Stat Tek: a reagent-strip method for glucose determination.
Clinical biochemistry 1980;13(1):60-1.
1979: Chan D W; Rock R C; Wiegand N J
Determination of bilirubin in pediatric samples: a re-examination of the discrepancy between spectrophotometric and chemical methods.
Clinical biochemistry 1979;12(5):184-5.
1977: Chan D W; Slaunwhite W R
The chemistry of human transcortin. The effects of pH, urea, salt, and temperature on the binding of cortisol and progesterone.
Archives of biochemistry and biophysics 1977;182(2):437-42.
1977: Chan D W; Sharma M; Slaunwhite W R
The chemistry of human transcortin. Improved affinity matrices for the purification of transcortin.
Archives of biochemistry and biophysics 1977;182(1):197-202.
1977: Chan D W; Slaunwhite W R
The binding of a synthetic progestin, R5020 to transcortin and serum albumin.
The Journal of clinical endocrinology and metabolism 1977;44(5):983-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Daniel Chan

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Occupations

Procedures

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Daniel Chan (preview)

All Publications